Irina N. Gaisina

The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicity

Nichole E. LaPointe, Gerardo Morfini, Gustavo Pigino et al. · Journal of Neuroscience Research · 2008 · 235 citations

Life Sciences, Neurobiology, Neuroscience +17

Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease

Manuj Ahuja, Navneet Ammal Kaidery, Lichuan Yang et al. · Journal of Neuroscience · 2016 · 206 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors That Suppress Proliferation and Survival of Pancreatic Cancer Cells

Irina N. Gaisina, Franck Gallier, Andrei V. Ougolkov et al. · Journal of Medicinal Chemistry · 2009 · 127 citations · Full text

Medicine, Oncology, Pharmacology +15

Highly Potent and Specific GSK‐3β Inhibitors That Block Tau Phosphorylation and Decrease α‐Synuclein Protein Expression in a Cellular Model of Parkinson's Disease

Alan P. Kozikowski, Irina N. Gaisina, Pavel A. Petukhov et al. · ChemMedChem · 2006 · 100 citations

Life Sciences, Neuroscience, Pharmacology +16

Structure-Based Design Leads to the Identification of Lithium Mimetics That Block Mania-like Effects in Rodents. Possible New GSK-3β Therapies for Bipolar Disorders

Alan P. Kozikowski, Irina N. Gaisina, Pavel A. Petukhov et al. · Journal of the American Chemical Society · 2007 · 89 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17